Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Moderna Inc MRNA

Healthcare Biotechnology
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:MRNA)

Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates

ACCESS Newswire 7 days ago

Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma

ACCESS Newswire 10 days ago

Moderna Named a Top Employer by Science for Eleventh Consecutive Year

ACCESS Newswire October 23, 2025

Moderna to Host Investor Event - Analyst Day

ACCESS Newswire October 23, 2025

Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint

ACCESS Newswire October 22, 2025

Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025

ACCESS Newswire October 19, 2025

Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

ACCESS Newswire October 16, 2025

Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress

ACCESS Newswire October 12, 2025

Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK

ACCESS Newswire September 24, 2025
View More News ››

Opinion & Analysis (NDAQ:MRNA)

Rich TV Live's Stocks to Watch this week (Aug. 23, 2024)

Rich TV Live August 23, 2024

Rich TV Live's Stocks to Watch this week (Aug. 16, 2024)

Rich TV Live August 16, 2024

Memphasys, Moderna, Paion - Investments in solutions with potential

Stockhouse Editorial June 2, 2020

Moderna Shares Rise 25% on Positive Phase 1 Coronavirus Vaccine Trial Data

Streetwise Reports May 19, 2020

BARDA Award Provides 'Lift-off for Biotech's COVID Vaccine'

Streetwise Reports April 23, 2020

U.S.-Based Biotech 'Growing into a Giant with AI'

Streetwise Reports March 9, 2020
View More Opinion ››

Bullboard Posts (NDAQ:MRNA)

Moderna dips as bird flu death sparks vaccine focus

Moderna's stock surged over 10% after the first U.S. bird flu death, highlighting the company's H5N1 vaccine development. 
MarketWolf2024 - January 8, 2025

RE:Oversold. Over beaten.

Agreed, this is a $75 stock any day of the week. $21 per share in cash on the books with no debt. Impressive pipeline with several...
ssomervst - January 2, 2025

Oversold. Over beaten.

Way too much potential, it is just a question of Time for the sector. when it Will turn, it Will go back up quickly. glta dyodd
ecolo101 - December 14, 2024

MRNA Ascending Triangle Long Setup on the Downtrend!

Spotted a clean ascending triangle on the downtrend. Breakout above $46 and EMA200 = long play. Entry: $46.4, Stop: $42.5, Target: $57...
IronFocus77 - December 6, 2024

Hurry up....

hThis site just sent me a 68% winner. ttp://stockscreener.tech
rizashakur29 - November 18, 2022

Moderna Shares Soar As Company Announces $3 Billion Stock Bu

Moderna Inc shares on Wednesday soared as high as 17% after it announced that it would be buying back up to US$3 billion of its stock...
AwareInvestor - August 4, 2022
View more Bullboard ››

Alvopetro Energy Ltd.

Alvopetro Energy Ltd.

Alvopetro Energy Ltd. is a Canada-based company, which is engaged in the exploration for and the acquisition, development and ...
View More »